ATXN3

Chr 14ADMulti

ataxin 3

Also known as: AT3, ATX3, JOS, MJD, MJD1, SCA3

Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 12-44 to 52-86 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2016]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAD/MultiLOEUF 0.492 OMIM phenotypes
Clinical SummaryATXN3
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 48 VUS of 111 total submissions
📖
GeneReview available — ATXN3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.49LOEUF
pLI 0.106
Z-score 3.53
OE 0.26 (0.150.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.35Z-score
OE missense 0.72 (0.630.83)
136 obs / 188.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.26 (0.150.49)
00.351.4
Missense OE?0.72 (0.630.83)
00.61.4
Synonymous OE?0.81
01.21.6
LoF obs/exp: 7 / 26.7Missense obs/exp: 136 / 188.0Syn Z: 1.21

This gene — mechanism propensity

DN
0.74top 25%
GOF
0.6931th %ile
LOF
0.2580th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports gain-of-function. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFComparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 28854700

ClinVar Variant Classifications

111 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic1
VUS48
Likely Benign12
Benign15
Conflicting2
1
Pathogenic
1
Likely Pathogenic
48
VUS
12
Likely Benign
15
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
1
0
0
0
1
VUS
6
40
2
0
48
Likely Benign
3
6
2
1
12
Benign
2
11
1
1
15
Conflicting
2
Total12576279

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 26) ClinVar copy-number / structural variants overlap ATXN3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ATXN3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →